Vogenx (VOGX)
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and g...
- Open
- 31.040
- High
- 35.500
- Low
- 30.800
- Prev. Close
- 30.730
- Volume
- 87.22K
- Turnover
- 2.92M
- Avg Price
- 33.481
- Bid/Ask Ratio
- -50.45%
- Amplitude
- 15.29%
- 52wk High
- 35.500
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.98%
News
- rttnews · 8 hours ago
Biotech Stocks At 52-Week Highs - VOGX, PHVS, SOLV, IKT, HTFL
- Weekly Review · Aug 22 at 12:55 AM
Weekly Recap | Vogenx +99.73%, IPO debut drives surge
- PUBT · Aug 19 at 03:09 PM
Vogenx IPO raises USD 81.25 million at USD 13 per share
- Price Alert · Aug 19 at 10:38 AM
U.S. stock market midday update: VOGX rises 19.75%, hitting a new 60-day high, IPO fundraising of $81.3 million boosts confidence
- rttnews · Aug 19 at 03:26 AM
Biotech Stocks At 52-Week Highs - AMLX +63% With Phase 3 Data, VOGX +25%, OBIO +19%, ATRC, CRL
- rttnews · Aug 17 at 09:13 PM
After-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Day
